{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:20:15Z","timestamp":1789154415271,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,8]]},"DOI":"10.7759\/cureus.81867","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T08:26:56Z","timestamp":1744100816000},"source":"Crossref","is-referenced-by-count":2,"title":["Severe Neutropenia Due to Carbimazole and the Importance of Early Recognition and Management"],"prefix":"10.7759","author":[{"given":"Anup","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eazaz Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470422","article-title":"Use of colony-stimulating factors for the treatment of carbimazole-induced agranulocytosis","volume":"47","author":"Genet P","year":"1994","unstructured":"Genet P, Pulik M, Lionnet F, Bremont C. Use of colony-stimulating factors for the treatment of carbimazole-induced agranulocytosis. Am J Hematol. 1994, 47:334-5. 10.1002\/ajh.2830470422","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","article-title":"Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes","volume":"79","author":"Juli\u00e1 A","year":"1991","unstructured":"Juli\u00e1 A, Olona M, Bueno J, et al.. Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol. 1991, 79:366-71. 10.1111\/j.1365-2141.1991.tb08042.x","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-1-26","article-title":"Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose","volume":"98","author":"Cooper DS","year":"1983","unstructured":"Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, Ridgway EC. Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose. Ann Intern Med. 1983, 98:26-9. 10.7326\/0003-4819-98-1-26","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.49.29","article-title":"Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis","volume":"49","author":"Dai WX","year":"2002","unstructured":"Dai WX, Zhang JD, Zhan SW, et al.. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis. Endocr J. 2002, 49:29-33. 10.1507\/endocrj.49.29","journal-title":"Endocr J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug-induced agranulocytosis: the usefulness of routine white blood cell count monitoring","volume":"150","author":"Tajiri J","year":"1990","unstructured":"Tajiri J, Noguchi S, Murakami T, Murakami. Antithyroid drug-induced agranulocytosis: the usefulness of routine white blood cell count monitoring. Arch Intern Med. 1990, 150:621-4. 10.1001\/archinte.1990.00390150107020","journal-title":"Arch Intern Med"},{"key":"ref7","article-title":"The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases","volume":"8","author":"Sprikkelman A","year":"1994","unstructured":"Sprikkelman A, de Wolf JT, Vellenga E. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia. 1994, 8:2031-6.","journal-title":"Leukemia"},{"key":"ref8","article-title":"Carbimazole induced agranulocytosis with life-threatening complications, tremendous response with granulocyte-colony stimulating factor","volume":"9","author":"Mahant S","year":"2016","unstructured":"Mahant S, Shobhane U, Mahant PD. Carbimazole induced agranulocytosis with life-threatening complications, tremendous response with granulocyte-colony stimulating factor. Med J Dr. D. Y. Patil Univ. 2016, 9:79-81.","journal-title":"Med J Dr. D. Y. Patil Univ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.11.12","article-title":"Clinical presentation and management of drug-induced agranulocytosis","volume":"4","author":"Andr\u00e8s E","year":"2011","unstructured":"Andr\u00e8s E, Zimmer J, Mecili M, Weitten T, Alt M, Maloisel F. Clinical presentation and management of drug-induced agranulocytosis. Expert Rev Hematol. 2011, 4:143-51. 10.1586\/ehm.11.12","journal-title":"Expert Rev Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2005.15.292","article-title":"Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?","volume":"15","author":"Tajiri J","year":"2005","unstructured":"Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?. Thyroid. 2005, 15:292-7. 10.1089\/thy.2005.15.292","journal-title":"Thyroid"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism","volume":"7","author":"Kahaly GJ","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism. Eur Thyroid J. 2018, 7:167-86. 10.1159\/000490384","journal-title":"Eur Thyroid J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/355428-severe-neutropenia-due-to-carbimazole-and-the-importance-of-early-recognition-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T08:27:06Z","timestamp":1744100826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/355428-severe-neutropenia-due-to-carbimazole-and-the-importance-of-early-recognition-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.81867","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,8]]}}}